Figure 3.
PFS and OS among 243 relapsed patients with T-NHL treated with chemotherapy in second-line.

PFS and OS among 243 relapsed patients with T-NHL treated with chemotherapy in second-line.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal